In recent months, UnitedHealth Group has raised premiums by around 20–30%, updated its 2025 earnings guidance, and faced ...

UnitedHealth Group stock is a top dividend growth stock with solid returns, reliable yield, and long-term growth prospects.

Wondering if UnitedHealth Group is a bargain or a value trap at today’s price? Let us unpack what the market is really implying about this healthcare giant. After a rough stretch that has left the ...

UnitedHealth Group (NYSE: UNH) has outperformed the market over the past 15 years by 4.15% on an annualized basis producing an average annual return of 16.05%. Currently, UnitedHealth Group has a ...

Discover why UnitedHealth Group (UNH) is rated Buy, with margin recovery, earnings growth, and 154% upside potential.

The health insurance giant's stock got a big boost after Wall Street learned Berkshire Hathaway had invested in it.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” ...

We came across a bullish thesis on UnitedHealth Group Incorporated on Value investing subreddit by ashm1987. In this article, ...

UnitedHealth Group has agreed to sell its last South American business Banmedica to Brazilian private equity group Patria Investments for $1 billion, two sources with knowledge of the matter said on ...

Former UnitedHealth Group CEO William McGuire joins mediation team for Fairview and University of Minnesota merger negotiations.

A NJ medical network owned by UnitedHealth will go out of network with more than 10 health insurances next month, they said.